Micro RNA expressions of chronic hepatitis related hepatocellular carcinoma

慢性肝炎相关性肝细胞癌中微小RNA的表达

基本信息

  • 批准号:
    24790686
  • 负责人:
  • 金额:
    $ 2.83万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 财政年份:
    2012
  • 资助国家:
    日本
  • 起止时间:
    2012-04-01 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

DNA damage response genes in non-tumor lesions were associated with AP1 signaling which mediates the expression of many genes in CH-B-related HCC. In contrast, signal transducers and activators of transcription 1 and phosphatase and tensin homolog in non-tumor lesions were associated with early growth response protein 1 signaling that potentially promotes angiogenesis, fibrogenesis, and tumorigenesis in CH-C-related HCC. MicroRNAs were up- or down-regulated in cancerous tissue. These expression changes were confirmed as previously.Gene expression profiling of HCC and non-tumor lesions revealed the predisposing changes of gene expression in HCC. This approach has potential for the early diagnosis and possible prevention of HCC.
非肿瘤病变中的DNA损伤应答基因与AP1信号相关,AP1信号介导ch - b相关性HCC中许多基因的表达。相反,非肿瘤病变中转录1、磷酸酶和紧张素同源物的信号转导和激活因子与早期生长反应蛋白1信号相关,该信号可能促进ch - c相关HCC的血管生成、纤维生成和肿瘤发生。microrna在癌组织中被上调或下调。这些表达变化与之前一样得到证实。HCC和非肿瘤病变的基因表达谱揭示了HCC中基因表达的易感性变化。这种方法具有早期诊断和预防HCC的潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling
  • DOI:
    10.1016/j.ygeno.2013.02.007
  • 发表时间:
    2013-04-01
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Ueda, Teruyuki;Honda, Masao;Kaneko, Shuichi
  • 通讯作者:
    Kaneko, Shuichi
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

UEDA TERUYUKI其他文献

UEDA TERUYUKI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Atypical Chemokine Receptors orchestrate changes in vascular patterning during fibrotic liver disease via Endothelial-to-Mesenchymal Transition.
非典型趋化因子受体通过内皮-间质转化协调纤维化肝病期间血管模式的变化。
  • 批准号:
    MR/Y013751/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Research Grant
Investigation of Endocrine-Disrupting Chemicals as Contributors to Progression of Metabolic Dysfunction Associated Steatotic Liver Disease (EDC-MASLD)
内分泌干​​扰化学物质对代谢功能障碍相关脂肪性肝病 (EDC-MASLD) 进展的影响的调查
  • 批准号:
    10092670
  • 财政年份:
    2024
  • 资助金额:
    $ 2.83万
  • 项目类别:
    EU-Funded
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
  • 批准号:
    10087822
  • 财政年份:
    2024
  • 资助金额:
    $ 2.83万
  • 项目类别:
    EU-Funded
Multi-modal non-invasive biomarker screening for high-risk undiagnosed liver disease
针对高危未确诊肝病的多模式非侵入性生物标志物筛查
  • 批准号:
    10073169
  • 财政年份:
    2023
  • 资助金额:
    $ 2.83万
  • 项目类别:
    Collaborative R&D
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
  • 批准号:
    10354185
  • 财政年份:
    2023
  • 资助金额:
    $ 2.83万
  • 项目类别:
Multicellular Organotypic Mouse Model of Alcoholic Liver Disease
酒精性肝病的多细胞器官型小鼠模型
  • 批准号:
    10667672
  • 财政年份:
    2023
  • 资助金额:
    $ 2.83万
  • 项目类别:
Circadian and mitochondrial dysfunction in alcohol-related liver disease
酒精相关性肝病中的昼夜节律和线粒体功能障碍
  • 批准号:
    10667861
  • 财政年份:
    2023
  • 资助金额:
    $ 2.83万
  • 项目类别:
Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
全氟烷基物质与儿童非酒精性脂肪肝:利用磁共振成像揭示潜在机制和暴露混合物效应
  • 批准号:
    10646759
  • 财政年份:
    2023
  • 资助金额:
    $ 2.83万
  • 项目类别:
Cannabidiol as a treatment for alcoholic liver disease
大麻二酚治疗酒精性肝病
  • 批准号:
    10753729
  • 财政年份:
    2023
  • 资助金额:
    $ 2.83万
  • 项目类别:
Role of Interferon-Gamma / Interleukin-12 Axis in Metabolic Liver Disease
干扰素-γ/白介素-12 轴在代谢性肝病中的作用
  • 批准号:
    10735419
  • 财政年份:
    2023
  • 资助金额:
    $ 2.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了